Iqbal, A., Abbasi, Z. A. ., & Naeem, F. . (2022). Benefits of six week and personalized dosing of pembrolizumab considering ongoing delta variant surge. Journal of the Pakistan Medical Association, 72(3). https://doi.org/10.47391/JPMA.4660